146
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Cyclic adenosine monophosphate responsive element binding protein in post-traumatic stress disorder

, , , , , , & show all
Pages 396-402 | Received 24 Oct 2010, Accepted 28 Mar 2011, Published online: 23 Jun 2011
 

Abstract

Objectives. The cyclic adenosine monophosphate responsive element binding (CREB) protein is a transcription factor involved in different neural processes, such as learning, neuroplasticity and the modulation of stress response. Alterations in the CREB pathway have been observed in the brains and lymphocytes of patients affected by depression and alcohol abuse. Given the lack of information, our study aimed at investigating the levels of total and activated CREB protein in lympho-monocytes of 20 drug-free patients suffering from post-traumatic stress disorders (PTSD), as compared with 20 healthy control subjects. Methods. Blood samples were collected from patients and healthy control subjects on the same time and lympho-monocytes were isolated according to standardized methods. CREB protein levels and activation were measured by means of immunoenzymatic techniques. Results. The results showed that PTSD patients had statistically lower levels of total CREB protein in lympho-monocytes than healthy control subjects. On the contrary, no difference in the activated CREB protein was detected. Conclusions. These findings, albeit preliminary, would suggest that the CREB pathway might be involved in the pathophysiology of PTSD. Future studies should clarify if specific PTSD symptom clusters might be related to the CREB pathway.

Acknowledgements

This work was supported by the Italian Minister for the University Research (MIUR Grant 2006-2008). The MIUR had no further role in the study design, collection, analysis or interpretation of the data, the writing of the report or the decision to submit the paper for publication. We received assistance from the Scientific Editing Service “American Journal Experts” (AJE) in preparing the manuscript for publication. The authors are entirely responsible for the scientific content of the paper.

Statement of Interest

None to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.